Why the study?
Do rotavirus vaccines (RV1 and RV5) prevent rotavirus disease in children globally?
Population
Children from 24 countries across geographic regions and with different child mortality levels
Design
Systematic_review
Authors
Loading...
Rotavirus vaccines show substantial effectiveness across mortality settings; confirms postlicensure benefit and supports global routine immunization.
Do rotavirus vaccines (RV1 and RV5) prevent rotavirus disease in children globally?
Postlicensure data from the first decade demonstrates that both RV1 and RV5 are effective against rotavirus disease across different child mortality settings, supporting WHO recommendations for routine immunization.
Jonesteller et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: